Deloitte: 2017 life sciences and health care outlooks


What are the trends for US life sciences and health care companies in the coming year?

The shift from fee-for-service to fee-for-value is forcing health care providers to rethink their strategies under MACRA. A growing share of health care costs are shifting to consumers, causing health plans to continue their focus on affordability. Life sciences companies wrestle with shrinking research, development budgets, and pipelines, while under pressure to maintain or reduce costs.

All of these shifts are with the backdrop of new and game-changing technology, shifting customer demands, and perhaps most importantly, a new administration and uncertainty around the Affordable Care Act.

Deloitte’s 2017 Industry Outlooks explore the key trends and challenges providers, plans, and life sciences companies might face in coming year. Find out what strategies stakeholders can take to face and overcome strong headwinds. 

Share This Post:

Comments are closed.